212 related articles for article (PubMed ID: 29981619)
1. Triple-Negative Breast Cancer: A Comparison of Race and Survival.
Doepker MP; Holt SD; Durkin MW; Chu CH; Nottingham JM
Am Surg; 2018 Jun; 84(6):881-888. PubMed ID: 29981619
[TBL] [Abstract][Full Text] [Related]
2. Does race predict survival for women with invasive breast cancer?
Walsh SM; Zabor EC; Stempel M; Morrow M; Gemignani ML
Cancer; 2019 Sep; 125(18):3139-3146. PubMed ID: 31206623
[TBL] [Abstract][Full Text] [Related]
3. Correlates of Triple Negative Breast Cancer and Chemotherapy Patterns in Black and White Women With Breast Cancer.
Sheppard VB; Cavalli LR; Dash C; Kanaan YM; Dilawari AA; Horton S; Makambi KH
Clin Breast Cancer; 2017 Jun; 17(3):232-238. PubMed ID: 28189497
[TBL] [Abstract][Full Text] [Related]
4. Somatic mutations of triple-negative breast cancer: a comparison between Black and White women.
Omilian AR; Wei L; Hong CC; Bandera EV; Liu S; Khoury T; Ambrosone CB; Yao S
Breast Cancer Res Treat; 2020 Jul; 182(2):503-509. PubMed ID: 32441016
[TBL] [Abstract][Full Text] [Related]
5. A comparison between young and old patients with triple-negative breast cancer: biology, survival and metastatic patterns.
Tzikas AK; Nemes S; Linderholm BK
Breast Cancer Res Treat; 2020 Aug; 182(3):643-654. PubMed ID: 32524352
[TBL] [Abstract][Full Text] [Related]
6. Features of triple-negative breast cancer: Analysis of 38,813 cases from the national cancer database.
Plasilova ML; Hayse B; Killelea BK; Horowitz NR; Chagpar AB; Lannin DR
Medicine (Baltimore); 2016 Aug; 95(35):e4614. PubMed ID: 27583878
[TBL] [Abstract][Full Text] [Related]
7. Black race as a prognostic factor in triple-negative breast cancer patients treated with breast-conserving therapy: a large, single-institution retrospective analysis.
Perez CA; Zumsteg ZS; Gupta G; Morrow M; Arnold B; Patil SM; Traina TA; Robson ME; Wen YH; McCormick B; Powell SN; Ho AY
Breast Cancer Res Treat; 2013 Jun; 139(2):497-506. PubMed ID: 23645006
[TBL] [Abstract][Full Text] [Related]
8. Reproductive factors and the risk of triple-negative breast cancer in white women and African-American women: a pooled analysis.
Ma H; Ursin G; Xu X; Lee E; Togawa K; Duan L; Lu Y; Malone KE; Marchbanks PA; McDonald JA; Simon MS; Folger SG; Sullivan-Halley J; Deapen DM; Press MF; Bernstein L
Breast Cancer Res; 2017 Jan; 19(1):6. PubMed ID: 28086982
[TBL] [Abstract][Full Text] [Related]
9. Mortality risk from comorbidities independent of triple-negative breast cancer status: NCI-SEER-based cohort analysis.
Swede H; Sarwar A; Magge A; Braithwaite D; Cook LS; Gregorio DI; Jones BA; R Hoag J; Gonsalves L; L Salner A; Zarfos K; Andemariam B; Stevens RG; G Dugan A; Pensa M; A Brockmeyer J
Cancer Causes Control; 2016 May; 27(5):627-36. PubMed ID: 27000206
[TBL] [Abstract][Full Text] [Related]
10. Breast-conserving therapy for triple-negative breast cancer.
Gangi A; Chung A; Mirocha J; Liou DZ; Leong T; Giuliano AE
JAMA Surg; 2014 Mar; 149(3):252-8. PubMed ID: 24382582
[TBL] [Abstract][Full Text] [Related]
11. Association of sonographic features and molecular subtypes in predicting breast cancer disease outcomes.
Wang H; Yao J; Zhu Y; Zhan W; Chen X; Shen K
Cancer Med; 2020 Sep; 9(17):6173-6185. PubMed ID: 32657039
[TBL] [Abstract][Full Text] [Related]
12. Comparative Analysis of Breast Cancer Phenotypes in African American, White American, and West Versus East African patients: Correlation Between African Ancestry and Triple-Negative Breast Cancer.
Jiagge E; Jibril AS; Chitale D; Bensenhaver JM; Awuah B; Hoenerhoff M; Adjei E; Bekele M; Abebe E; Nathanson SD; Gyan K; Salem B; Oppong J; Aitpillah F; Kyei I; Bonsu EO; Proctor E; Merajver SD; Wicha M; Stark A; Newman LA
Ann Surg Oncol; 2016 Nov; 23(12):3843-3849. PubMed ID: 27469125
[TBL] [Abstract][Full Text] [Related]
13. Risk factors associated with the triple-negative breast cancer subtype within four race/ethnicities.
Parise CA; Caggiano V
Breast Cancer Res Treat; 2017 May; 163(1):151-158. PubMed ID: 28213780
[TBL] [Abstract][Full Text] [Related]
14. Outcome disparities in African American women with triple negative breast cancer: a comparison of epidemiological and molecular factors between African American and Caucasian women with triple negative breast cancer.
Sturtz LA; Melley J; Mamula K; Shriver CD; Ellsworth RE
BMC Cancer; 2014 Feb; 14():62. PubMed ID: 24495414
[TBL] [Abstract][Full Text] [Related]
15. Patterns of Failure in Triple Negative Breast Cancer Patients in an Urban, Predominately Black Population.
Cherng HR; Rice SR; Hamza M; Murali S; Rosenblatt P; Tkaczuk KHR; Bellavance E; Cheston S; Amin N; Nichols E
J Racial Ethn Health Disparities; 2021 Aug; 8(4):1035-1046. PubMed ID: 32888170
[TBL] [Abstract][Full Text] [Related]
16. Triple-negative breast cancer incidence in the United States: ecological correlations with area-level sociodemographics, healthcare, and health behaviors.
Moss JL; Tatalovich Z; Zhu L; Morgan C; Cronin KA
Breast Cancer; 2021 Jan; 28(1):82-91. PubMed ID: 32671723
[TBL] [Abstract][Full Text] [Related]
17. High triple-negative breast cancer prevalence and aggressive prognostic factors in Barbadian women with breast cancer.
Hercules SM; Hercules JC; Ansari A; Date SAJ; Skeete DHA; Smith Connell SP; Pond GR; Daniel JM
Cancer; 2020 May; 126(10):2217-2224. PubMed ID: 32154924
[TBL] [Abstract][Full Text] [Related]
18. Racial and Ethnic Differences in Breast Cancer Survival: Mediating Effect of Tumor Characteristics and Sociodemographic and Treatment Factors.
Warner ET; Tamimi RM; Hughes ME; Ottesen RA; Wong YN; Edge SB; Theriault RL; Blayney DW; Niland JC; Winer EP; Weeks JC; Partridge AH
J Clin Oncol; 2015 Jul; 33(20):2254-61. PubMed ID: 25964252
[TBL] [Abstract][Full Text] [Related]
19. Analysis of Risk of Recurrence by Subtype in ≤ 1-cm Breast Tumors.
Colonna SV; Higgins AK; Alvarez J; Saville BR; Lawrence J; Abramson VG
Clin Breast Cancer; 2016 Jun; 16(3):223-31. PubMed ID: 26683741
[TBL] [Abstract][Full Text] [Related]
20. Triple-negative breast cancer in African-American women: disparities versus biology.
Dietze EC; Sistrunk C; Miranda-Carboni G; O'Regan R; Seewaldt VL
Nat Rev Cancer; 2015 Apr; 15(4):248-54. PubMed ID: 25673085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
